EE05050B1 - Loteprednooli ja β2-adrenoretseptori agonistide kombinatsioon, selle kasutamine, seda kombinatsiooni sisaldav farmatseutiline preparaat ja ravim ning meetod seda kombinatsiooni sisaldava ravimivalmistamiseks - Google Patents
Loteprednooli ja β2-adrenoretseptori agonistide kombinatsioon, selle kasutamine, seda kombinatsiooni sisaldav farmatseutiline preparaat ja ravim ning meetod seda kombinatsiooni sisaldava ravimivalmistamiseksInfo
- Publication number
- EE05050B1 EE05050B1 EEP200200163A EEP200200163A EE05050B1 EE 05050 B1 EE05050 B1 EE 05050B1 EE P200200163 A EEP200200163 A EE P200200163A EE P200200163 A EEP200200163 A EE P200200163A EE 05050 B1 EE05050 B1 EE 05050B1
- Authority
- EE
- Estonia
- Prior art keywords
- combination
- medicament containing
- loteprednol
- preparing
- pharmaceutical preparation
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 2
- 239000000556 agonist Substances 0.000 title 1
- 102000014974 beta2-adrenergic receptor activity proteins Human genes 0.000 title 1
- 108040006828 beta2-adrenergic receptor activity proteins Proteins 0.000 title 1
- YPZVAYHNBBHPTO-MXRBDKCISA-N loteprednol Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)OCCl)[C@@H]4[C@@H]3CCC2=C1 YPZVAYHNBBHPTO-MXRBDKCISA-N 0.000 title 1
- 229960001798 loteprednol Drugs 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19947235A DE19947235A1 (de) | 1999-09-30 | 1999-09-30 | Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten |
| PCT/EP2000/009392 WO2001022956A2 (de) | 1999-09-30 | 2000-09-26 | NEUE KOMBINATION VON LOTEPREDNOL UND β2-ADRENOZEPTOR-AGONISTEN |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200200163A EE200200163A (et) | 2003-04-15 |
| EE05050B1 true EE05050B1 (et) | 2008-08-15 |
Family
ID=7924101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200163A EE05050B1 (et) | 1999-09-30 | 2000-09-26 | Loteprednooli ja β2-adrenoretseptori agonistide kombinatsioon, selle kasutamine, seda kombinatsiooni sisaldav farmatseutiline preparaat ja ravim ning meetod seda kombinatsiooni sisaldava ravimivalmistamiseks |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7521438B1 (pl) |
| EP (1) | EP1216047B1 (pl) |
| JP (1) | JP5068912B2 (pl) |
| AR (1) | AR025924A1 (pl) |
| AT (1) | ATE306271T1 (pl) |
| AU (1) | AU7907400A (pl) |
| BR (1) | BR0014374B1 (pl) |
| CA (1) | CA2389111C (pl) |
| CY (1) | CY1105548T1 (pl) |
| CZ (1) | CZ296396B6 (pl) |
| DE (2) | DE19947235A1 (pl) |
| DK (1) | DK1216047T3 (pl) |
| EE (1) | EE05050B1 (pl) |
| ES (1) | ES2248131T3 (pl) |
| HU (1) | HUP0202753A3 (pl) |
| MX (1) | MXPA02003329A (pl) |
| PL (1) | PL196729B1 (pl) |
| SI (1) | SI1216047T1 (pl) |
| TW (1) | TWI253930B (pl) |
| WO (1) | WO2001022956A2 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0012260D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| CN100450488C (zh) * | 2003-11-03 | 2009-01-14 | 诺顿·希尔思凯尔有限公司 | 用于干粉吸入剂的软类固醇组合物 |
| EP2221048A1 (en) * | 2009-02-18 | 2010-08-25 | Siegfried Generics International AG | Pharmaceutical composition for inhalation |
| US9238144B2 (en) * | 2013-03-14 | 2016-01-19 | Neuropace, Inc. | Optimizing data retrieval from an active implantable medical device |
| WO2022016150A1 (en) * | 2020-07-17 | 2022-01-20 | Ross Peter M | Methods for the treatment of cytokine release syndromes |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB416950A (en) * | 1933-07-28 | 1934-09-25 | Ambrose Heal | An improved support member for beds, settees, wardrobes and other articles of furniture |
| US4996335A (en) | 1980-07-10 | 1991-02-26 | Nicholas S. Bodor | Soft steroids having anti-inflammatory activity |
| ZA814440B (en) * | 1980-07-10 | 1982-10-27 | Otsuka Pharma Co Ltd | Soft steroids having anti-inflammatory activity |
| US4710495A (en) | 1980-07-10 | 1987-12-01 | Otsuka Pharmaceutical Co., Ltd. | Soft steroids having anti-inflammatory activity |
| TW503113B (en) * | 1997-01-16 | 2002-09-21 | Senju Pharma Co | Aqueous suspension for nasal administration |
| US6461591B1 (en) * | 1997-02-05 | 2002-10-08 | Jago Research Ag | Medical aerosol formulations |
| US5830490A (en) | 1997-04-04 | 1998-11-03 | Weinstein; Robert E. | Method and device for organizing and coordinating the combined use of topical aerosols and oral medications for the treatment of disorders |
| RU2221552C2 (ru) | 1998-11-13 | 2004-01-20 | Джаго Рисерч Аг | Сухой порошок для ингаляции |
-
1999
- 1999-09-30 DE DE19947235A patent/DE19947235A1/de not_active Withdrawn
-
2000
- 2000-09-26 AU AU79074/00A patent/AU7907400A/en not_active Abandoned
- 2000-09-26 ES ES00969304T patent/ES2248131T3/es not_active Expired - Lifetime
- 2000-09-26 US US10/089,449 patent/US7521438B1/en not_active Expired - Fee Related
- 2000-09-26 DK DK00969304T patent/DK1216047T3/da active
- 2000-09-26 BR BRPI0014374-0A patent/BR0014374B1/pt not_active IP Right Cessation
- 2000-09-26 SI SI200030769T patent/SI1216047T1/sl unknown
- 2000-09-26 CA CA002389111A patent/CA2389111C/en not_active Expired - Lifetime
- 2000-09-26 JP JP2001526168A patent/JP5068912B2/ja not_active Expired - Fee Related
- 2000-09-26 HU HU0202753A patent/HUP0202753A3/hu unknown
- 2000-09-26 AT AT00969304T patent/ATE306271T1/de active
- 2000-09-26 MX MXPA02003329A patent/MXPA02003329A/es active IP Right Grant
- 2000-09-26 EP EP00969304A patent/EP1216047B1/de not_active Expired - Lifetime
- 2000-09-26 EE EEP200200163A patent/EE05050B1/xx not_active IP Right Cessation
- 2000-09-26 DE DE50011340T patent/DE50011340D1/de not_active Expired - Lifetime
- 2000-09-26 TW TW089119863A patent/TWI253930B/zh not_active IP Right Cessation
- 2000-09-26 PL PL353487A patent/PL196729B1/pl not_active IP Right Cessation
- 2000-09-26 CZ CZ20021095A patent/CZ296396B6/cs not_active IP Right Cessation
- 2000-09-26 WO PCT/EP2000/009392 patent/WO2001022956A2/de not_active Ceased
- 2000-09-29 AR ARP000105167A patent/AR025924A1/es not_active Application Discontinuation
-
2005
- 2005-12-15 CY CY20051101559T patent/CY1105548T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5068912B2 (ja) | 2012-11-07 |
| CZ296396B6 (cs) | 2006-03-15 |
| PL196729B1 (pl) | 2008-01-31 |
| CZ20021095A3 (cs) | 2002-08-14 |
| WO2001022956A3 (de) | 2001-10-11 |
| TWI253930B (en) | 2006-05-01 |
| AR025924A1 (es) | 2002-12-18 |
| JP2003510276A (ja) | 2003-03-18 |
| DE19947235A1 (de) | 2001-04-05 |
| DE50011340D1 (de) | 2006-02-23 |
| EP1216047A2 (de) | 2002-06-26 |
| MXPA02003329A (es) | 2004-09-10 |
| BR0014374A (pt) | 2002-06-25 |
| EE200200163A (et) | 2003-04-15 |
| DK1216047T3 (da) | 2006-02-13 |
| US7521438B1 (en) | 2009-04-21 |
| SI1216047T1 (sl) | 2006-02-28 |
| ES2248131T3 (es) | 2006-03-16 |
| BR0014374B1 (pt) | 2012-12-25 |
| HUP0202753A2 (hu) | 2002-12-28 |
| PL353487A1 (pl) | 2003-11-17 |
| EP1216047B1 (de) | 2005-10-12 |
| CY1105548T1 (el) | 2010-07-28 |
| AU7907400A (en) | 2001-04-30 |
| ATE306271T1 (de) | 2005-10-15 |
| CA2389111C (en) | 2009-04-14 |
| HUP0202753A3 (en) | 2004-06-28 |
| WO2001022956A2 (de) | 2001-04-05 |
| CA2389111A1 (en) | 2001-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04997B1 (et) | Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine | |
| EE05506B1 (et) | Ravimi manustamise vahend eriti progestiinide jastrogeenide manustamiseks | |
| EE03594B1 (et) | Depooravimiks sobiv farmatseutiline kompositsioon, selle valmistamismeetod ja kasutamine | |
| EE04417B1 (et) | Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm, selle valmistamise meetod ja kasutamine | |
| HUP0101512A3 (en) | Adhesive microsphere drug delivery composition, process for its preparation and device containing it | |
| EE200000482A (et) | Glütsiini ülekannet pärssiva ühendi kasutamine ravimi valmistamiseks, ühend, seda sisaldav kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks | |
| EE200000483A (et) | Glütsiini ülekannet pärssiva ühendi kasutamine ravimi valmistamiseks, ühend, seda sisaldav kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks | |
| EE200100431A (et) | 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine | |
| EE04464B1 (et) | Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid | |
| HUP0301325A3 (en) | Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition | |
| EE200300587A (et) | Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine | |
| IL148870A0 (en) | 2'-substituted 1, 1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds | |
| HUP0105313A3 (en) | Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use | |
| EE200000596A (et) | Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod | |
| TW595475U (en) | Teat nozzle for paediatric oral dosing of fluid medicament, dosing device and kit comprising the same | |
| PL398391A1 (pl) | Koniugat hydroksyalkiloskrobi i polipeptydu, sposób wytwarzania tego koniugatu, jego zastosowanie oraz kompozycja farmaceutyczna zawierająca koniugat hydroksyalkiloskrobi i polipeptydu | |
| EE04490B1 (et) | Ühend, selle valmistamise meetod ning kasutamine meditsiinis | |
| HUP0301333A3 (en) | Pharmaceutical superdisintegrant, process for its preparation and its use | |
| EE05168B1 (et) | N-guanidinoalklamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine | |
| EE05050B1 (et) | Loteprednooli ja β2-adrenoretseptori agonistide kombinatsioon, selle kasutamine, seda kombinatsiooni sisaldav farmatseutiline preparaat ja ravim ning meetod seda kombinatsiooni sisaldava ravimivalmistamiseks | |
| EE04855B1 (et) | Hüübimistegurit pärssiv ühend, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaatning raviotstarbeline kasutamine | |
| EE04914B1 (et) | Eletriptaanvesinikbromiidi monohüdraat, selle kasutamine ja protsess selle valmistamiseks ning eletriptaanvesinikbromiidi monohüdraati sisaldav farmatseutiline kompositsioon | |
| EE200100615A (et) | Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat | |
| EE200200493A (et) | Lipiidne kandesüsteem, selle kasutamine ravimpreparaatide valmistamiseks ning seda sisaldav farmatseutiline kompositsioon | |
| EE200300398A (et) | Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HE1A | Change of address | ||
| HC1A | Change of owner name | ||
| KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20130926 |